Merck's Maurice R. Hillman Center for Vaccine Manufacturing in Durham (Treyburn), NC is on board to help with boosting production of Johnson & Johnson's COVID-19 vaccine. The plant will provide the bulk drug substance (biological active pharmaceutical ingredient) for the drug. One of two plants designated to help produce the drug, the Durham facility has $800 million in active capital expansion projects.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
